Home > News > PerkinElmer Announces New E-Learning Course for Optima ICP

  •   PerkinElmer Announces New E-Learning Course for Optima ICP

Latest Addition to Extensive Online Curriculum Available 24/7 to Help Customers Maximize Productivity, Throughput and Uptime

BOSTON, MA -- October 25, 2005 -- PerkinElmer Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced the availability of a new e-learning course designed to help customers troubleshoot and ensure proper preventive maintenance of the PerkinElmer OptimaTM family of Inductively Coupled Plasma (ICP) instruments. The curriculum is the latest addition to PerkinElmer’s 60 plus online courses designed to help advance the pace and precision of scientists’ research and testing through easily accessible, high quality training and education.

“Our online training offerings align with the customer trend toward decentralized, convenient and time-saving education enabling them to better manage training costs,” said Gary Grecsek, director of global customer training for PerkinElmer Life and Analytical Sciences.

“Ways to troubleshoot and maximize productivity with Optima instrumentation is high on our customers’ list of requests for new online curriculum,” Grecsek added. “We’ve responded by tapping the deep expertise of our internal product experts who work with customers every day on ICP challenges to ensure the training is on-target and actionable – and easily accessible online around the globe.”

The basic curriculum module focuses on maximizing uptime and includes routine maintenance procedures and lab safety requirements. It can serve as an overview of important topics for new users or as a helpful refresher for those who previously attended PerkinElmer’s intensive 5-day ICP classroom training. An advanced module covers in-depth maintenance procedures, including maintenance of the sample introduction system.

Grecsek noted that online learning is a growing trend among customers in the petrochemical, mining, and food and beverage industries, in addition to its extensive use in the pharmaceutical industry. “Online education is an effective vehicle for a consistently high level of training with documented employee participation,” he said.

Register Now and Save
The ICP course is one of many e-learning solutions from PerkinElmer for topics ranging from life sciences to instrument maintenance. The course structure allows learning at the student’s own pace at any time or location. With any paid registration through Dec. 31, 2006, a 50 percent discount is offered on any of the 21 online OneSource courses.

For more information, visit http://las.perkinelmer.com/Trainings/CourseSearch.htm


Factors Affecting Future Performance
This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) our failure to protect adequately our intellectual property; (4) the loss of any of our licenses or licensed rights; (5) our ability to compete effectively; (6) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (7) our ability to produce an adequate quantity of products to meet our customers’ demands; (8) our failure to maintain compliance with applicable government regulations; (9) regulatory changes; (10) economic, political and other risks associated with foreign operations; (11) our ability to retain key personnel; (12) restrictions in our credit agreement; (13) our ability to realize the full value of our intangible assets; and (14) other factors which we describe under the caption “Risk Factors” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.


Other Information
Health Sciences end markets include genetic screening, environmental, service, biopharma, and medical imaging. Photonics markets include sensors and specialty lighting.


About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of almost $2 billion in 2008, has approximately 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.


For Further Information
Media Contact
Ellen Wein
+1 (412) 456-0986